28 results on '"Hao, Xue-Zhi"'
Search Results
2. Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR‐mutant non‐small cell lung cancer.
3. Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study)
4. Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review
5. A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations
6. Efficacy of dacomitinib in patients with EGFR ‐mutated NSCLC and brain metastases
7. Immunohistochemistry reliably detects ALK rearrangements in patients with advanced non-small-cell lung cancer
8. Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients
9. Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial
10. Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial
11. Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer
12. Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI
13. Analysis of clinicopathological features of the echinoderm microtubule-associated protein-like-4-anaplastic lymphoma kinase fusion gene in Chinese patients with advanced non-small-cell lung cancer
14. Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma
15. Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer
16. Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in C hina
17. Analysis of clinicopathological features of the echinoderm microtubule-associated protein-like-4-anaplastic lymphoma kinase fusion gene in Chinese patients with advanced non-small-cell lung cancer
18. The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy
19. Abstract 2362: Detection of alk rearrangement in advanced non-small cell lung cancer using fluorescent in situ hybridization,immunohistochemistry,reverse transcription-polymerase chain reaction.
20. Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma.
21. The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy.
22. Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer.
23. [Efficacy of erlotinib after the failure of gefitinib in patients with metastasis of non-small cell lung cancer with unknown EGFR mutation status].
24. [Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer].
25. [Multicenter phase II clinical trial of arsenic trioxide injection in the treatment of primary hepatocarcinoma].
26. [Association of serum EGFR protein concentration with the efficacy of Gefitinib in the treatment of advanced non-small cell lung cancer].
27. [Factors affecting the sensitivity of EGFR-TKI treatment in advanced non-small cell lung cancer].
28. [Analysis of chemotherapeutic efficacy after a failed regimen of epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced non-small cell lung carcinoma].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.